R&D to Revenue
22.98%
Fiscal year · Period ending:

GLAXF R&D to Revenue
What is r&d to revenue?
R&D spending as percentage of revenue.
GLAXF r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 22.9834% | |
| 17.5198% | |
| 17.2942% | |
| 16.4916% | |
| 17.76% | |
| 13.1353% | |
| 12.5763% | |
| 11.8685% | |
| 12.8039% | |
| 12.4816% | |
| 14.2959% | |
| 14.4962% | |
| 12.9636% | |
| 13.1928% | |
| 13.4553% | |
| 15.1557% | |
| 14.0052% | |
| 14.7216% | |
| 14.3335% | |
| 14.8848% | |
| 14.4783% | |
| 14.5302% | |
| 13.0171% | |
| 13.6715% | |
| 12.4715% | |
| 13.972% | |
| 14.947% | |
| 14.5685% | |
| 14.386% | |
| 13.9192% | |
| 14.6806% | |
| 0% | |
| 15.1697% | |
| 14.9899% | |
| 14.5264% | |
| 13.9829% | |
| 13.2117% | |
| 12.5681% | |
| 11.1705% | |
| 8.5583% | |
| 7.9076% |
Frequently asked questions: GLAXF r&d to revenue
What is GSK plc (GLAXF)'s current r&d to revenue?
GSK plc (GLAXF)'s latest reported r&d to revenue (Fiscal year) is 22.98% as of Dec 31, 2025. R&D spending as percentage of revenue.
How much historical r&d to revenue data is available for GLAXF?
Stock Alarm Pro provides 41 dated annual fiscal periods observations for GSK plc (GLAXF)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare GLAXF's r&d to revenue to peers or set an alert?
You can open GLAXF's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GLAXF delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance